Teva Pharmaceutical Industries Ltd. (TEVA)

7.95
0.20 2.50
NYSE : Health Technology
Prev Close 8.15
Open 8.33
Day Low/High 7.84 / 8.33
52 Wk Low/High 6.07 / 23.97
Volume 27.02M
Avg Volume 20.59M
Exchange NYSE
Shares Outstanding 1.09B
Market Cap 7.76B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
Teva Nailed With S&P Downgrade

Teva Nailed With S&P Downgrade

The downgrade to BB from BBB- comes as the drugmaker continues to face challenges such as a competitive generic drug market in the U.S.

Teva Announces Launch Of A Generic Version Of Syprine® In The United States

Teva Announces Launch Of A Generic Version Of Syprine® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic version of Syprine ®1 (trientine hydrochloride) capsules, 250 mg, in the U.

Teva Shares Tank On Weak Outlook

Teva Shares Tank On Weak Outlook

The Israel-based drug maker reported fourth-quarter numbers that topped analysts' expectations, but its outlook came in below estimates.

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

What's Behind the Hound of Hades' Stock Market Rampage

What's Behind the Hound of Hades' Stock Market Rampage

The free market is going to take back control of interest rates.

Teva Reports 2017 Full Year And Fourth Quarter Financial Results

Teva Reports 2017 Full Year And Fourth Quarter Financial Results

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today reported results for the year and the quarter ended December 31, 2017.

This Is the Best Advice We Can Give After the Dow Jones Industrial Average Crash

This Is the Best Advice We Can Give After the Dow Jones Industrial Average Crash

The stock market continues to be under considerable pressure. Here is one thing not to do right now amidst the carnage.

Investors Learned One Valuable Lesson Watching the Dow's 1,175-Point Crash

Investors Learned One Valuable Lesson Watching the Dow's 1,175-Point Crash

The Dow Jones Industrial Average blew up on Monday, plain and simple. Here is one lesson investors should have learned.

European Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization Application

European Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization Application

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for fremanezumab, an anti-calcitonin...

Teva Completes Amendment To Credit Facilities

Teva Completes Amendment To Credit Facilities

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced amendments to its USD and JPY term loan and revolving credit facilities, providing the company greater flexibility in its financial leverage ratio...

Teva Announces Completion Of Global Women's Health Divestiture To CVC Capital Partners

Teva Announces Completion Of Global Women's Health Divestiture To CVC Capital Partners

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced it has completed the sale of a portfolio of products within its global women's health business across contraception, fertility, menopause and...

Teva To Host Conference Call To Discuss Fourth Quarter And Full Year 2017 Financial Results At 8 A.m. ET On February 8, 2018

Teva To Host Conference Call To Discuss Fourth Quarter And Full Year 2017 Financial Results At 8 A.m. ET On February 8, 2018

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2017 financial results on Thursday, February 8, 2018 at 7:00 a.

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

New York City sues Purdue Pharma, Teva Pharmaceutical, Allergan, Johnson and Johnson, Endo International, McKesson, AmerisourceBergen and Cardinal Health over how opioids have devastated the city and its services.

Are Politics and Proxy Firms Killing Your Investment Returns?

Are Politics and Proxy Firms Killing Your Investment Returns?

Gains are being left on the table as firms and investors let their politics or social concerns get the better of them.

Are Politics and Proxy Firms Hurting Your Investment Returns?

Stick to the fundamentals when making investment decisions.

Teva Announces Top-Line Results From Phase III Studies Of Subcutaneously Administered Reslizumab In Patients With Severe Eosinophilic Asthma

Teva Announces Top-Line Results From Phase III Studies Of Subcutaneously Administered Reslizumab In Patients With Severe Eosinophilic Asthma

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that a Phase III registration study evaluating subcutaneously administered reslizumab (110 mg) in a pre-filled syringe did not meet its primary...

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

As opioid crisis becomes more deadly, public hearings put the pain killers front and center. But in bitterly divided Washington one meeting is more about chopping Medicaid.

Teva Announces U.S. FDA Approval Of TRISENOX® (arsenic Trioxide) Injection For First Line Treatment Of Acute Promyelocytic Leukemia

Teva Announces U.S. FDA Approval Of TRISENOX® (arsenic Trioxide) Injection For First Line Treatment Of Acute Promyelocytic Leukemia

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that the U.

Teva Announces Global License Agreement With Alder BioPharmaceuticals® In The Field Of Anti-CGRP-Based Therapy

Teva Announces Global License Agreement With Alder BioPharmaceuticals® In The Field Of Anti-CGRP-Based Therapy

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced that its subsidiary, Teva Pharmaceuticals International GmbH.

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

The crisis could seemingly turn a number of companies on their heads much in the way that big tobacco suits of the late 1990s forever changed the tobacco industry.

Teva To Present At The 36th Annual J.P. Morgan Healthcare Conference

Teva To Present At The 36th Annual J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 36 th Annual J.

Teva Announces Launch Of An Authorized Generic Of Estrace® Cream In The United States

Teva Announces Launch Of An Authorized Generic Of Estrace® Cream In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of an authorized generic of Estrace ®1 Cream (estradiol vaginal cream, USP, 0.

Teva Still Has Big Problems It Must Deal With in 2018

Teva Still Has Big Problems It Must Deal With in 2018

The struggling drug company needs to take some major steps to address its massive debt load, analysts say.

Teva Announces Exclusive Launch Of A Generic Version Of Reyataz® In The United States

Teva Announces Exclusive Launch Of A Generic Version Of Reyataz® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the exclusive launch of a generic version of Reyataz ®1 (atazanavir) capsules in the U.

Try This Pair of Biotech Trades

Try This Pair of Biotech Trades

Teva and Mallinckrodt both lost over 50% of their value in 2017 and might catch some momentum here.

Teva Shares Rocket Higher Erasing Loses; CSX Savior Takes Leave -- ICYMI

Teva Shares Rocket Higher Erasing Loses; CSX Savior Takes Leave -- ICYMI

Here's what you need to know now for Friday, Dec. 15.

Teva Pharmaceutical 'Turned a Corner' This Week: Goldman Sachs

Teva Pharmaceutical 'Turned a Corner' This Week: Goldman Sachs

The Petach Tikva, Israel-based drugmaker on Dec. 15 launched generic Viread a day after announcing plans to cut 14,000 jobs globally over the next two years as part of restructuring efforts. Here come the upgrades.

Teva Announces Exclusive Launch Of Generic Viread® In The United States

Teva Announces Exclusive Launch Of Generic Viread® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the exclusive launch of generic Viread ®1 (tenofovir disoproxil fumarate) tablets 300 mg in the U.

Teva Closes Higher as Generic Drugmaker Announces Massive Layoffs, Asset Sales

Teva Closes Higher as Generic Drugmaker Announces Massive Layoffs, Asset Sales

The job cuts are part of the Petach Tikva, Israel-based drugmaker's restructuring efforts aimed at lowering its total cost base by $3 billion by the end of 2019.

TheStreet Quant Rating: D (Sell)